A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers

NCT06527755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin-mediated Amyloidosis

Interventions

DRUG: Eplontersen Solution for Injection

Sponsor

AstraZeneca